After having already obtained patent approval for product Scarletred®Vision in EU and USA we can now positively report that IP protection could be expanded also to Japan and Australia. Our granted method patent covers a broad set of technology claims for objective and quantitative documentation and analysis of changes in skin color and in particular for assessing erythema with a today total skin market of 1.35 billion people. Especially remote areas in Australia are targeted by our novel upcoming Tele-Dermatology services whereas Japan reflects a promising future market for novel cosmetics B2C applications.
SCARLEDRED: Patents granted in Japan and Australia
The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.
As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.